90
Participants
Start Date
December 28, 2023
Primary Completion Date
April 30, 2026
Study Completion Date
April 30, 2026
TCD601
Investigational Product
belatacept
Study Product
ATG
Comparator
TAC
Comparator
MPA
Immunosuppression Therapy
Corticosteroids
Immunosuppression Therapy
Mount Sinai Hospital, New York
Weill Cornell Medicine, New York
University of Pennsylvania, Philadelphia
Inova Fairfax Hospital Medical Campus, Falls Church
University of Virginia Health, Charlottesville
University of Virginia Hospital, Charlottesville
Atrium Health Wake Forest Baptist Medical Center, Winston-Salem
Medical University of South Carolina, Charleston
Emory University Hospital, Atlanta
Tampa General Hospital, Tampa
University of Cincinnati Medical Center, Cincinnati
University of Michigan Health System, Ann Arbor
Henry Ford Hospital, Detroit
Mayo Clinic, Rochester
Loyola University Medical Center, Maywood
Northwestern University, Chicago
Washington University in St. Louis (Barnes-Jewish Hospital), St Louis
University of Kansas Medical Center, Kansas City
University of Nebraska Medical Center, Omaha
Ochsner Clinic Foundation, New Orleans
Houston Methodist Hospital, Houston
UT Health San Antonio, San Antonio
University of Southern California, Los Angeles
Scripps Green Hospital, La Jolla
University of California San Francisco Medical Center, San Francisco
University of California Davis Medical Center, Sacramento
Massachusetts General Hospital, Boston
ITB-Med LLC
INDUSTRY